ミシガン州における2型糖尿病の臨床試験
ミシガン州内の拠点で、2型糖尿病に関する27件の研究が参加者を募集しています。
ミシガン州内の都市
公式研究テキスト（英語）
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
- University of Michigan, Ann Arbor
被験者募集中
18歳以上 · 全性別 · 2026/10/01更新 · NCT06906640Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
- University of Michigan, Ann Arbor
被験者募集中
18歳以上 · 全性別 · 2026/10/01更新 · NCT06906627A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Revival Research Institute, LLC, Dearborn
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07783802Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
- Northern Pines Hlth Ctr, PC, Buckley
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07817251EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Revival Research Institute, LLC - Dearborn, Dearborn
- Aa Mrc Llc, Flint
- Elite Research Center, LLC, Flint
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07064473A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- Northern Pines Health Center - Buckley, Buckley
- Revival Research Institute, LLC - Dearborn, Dearborn
- Arcturus Healthcare - Troy Internal Medicine Research Division, Troy
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07754461A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Henry Ford Hospital, Detroit
- Trinity Health Michigan Heart, Ypsilanti
被験者募集中健康なボランティア歓迎
55歳以上 · 全性別 · 2026/09/28更新 · NCT06112418A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Aa Mrc Llc, Flint
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07595549A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Farmington Hills
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07784270A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Southfield
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/16更新 · NCT07743450A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
- Elixia Health - Michigan Kidney Consultants, LLC - Elixia - PPDS, Pontiac
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/15更新 · NCT07340320Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- University of Michigan, Ann Arbor
- Elixia Michigan Kidney Consultants, Pontiac
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/11更新 · NCT07271186A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Southfield
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/09更新 · NCT07662213Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- Oakland Medical Research Center, Troy
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/09更新 · NCT07296484A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
- Great Lakes Research Inst., Southfield
被験者募集中第3相
10歳〜18歳 · 全性別 · 2026/09/09更新 · NCT07282613Mechanisms of Fatigability With Diabetes
- University of Michigan, Ann Arbor
被験者募集中
30歳〜85歳 · 全性別 · 2026/09/01更新 · NCT04442451AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Henry Ford Health System, Detroit
- Elite Research Center, Flint
- Arcturus Healthcare, PLC., Troy
- 他1件
被験者募集中第3相
45歳以上 · 全性別 · 2026/09/01更新 · NCT07797335A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Troy
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/31更新 · NCT07662109A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Research Site, Southfield
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/31更新 · NCT07662044Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
- Henry Ford Health System, Detroit
被験者募集中
18歳〜80歳 · 全性別 · 2026/08/28更新 · NCT07599982Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
- Henry Ford Health Systems, Detroit
被験者募集中
14歳〜75歳 · 全性別 · 2026/08/03更新 · NCT07579702Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
- Henry Ford Health, Detroit
被験者募集中
18歳〜75歳 · 全性別 · 2026/08/03更新 · NCT07521475Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
- University of Michigan, Ann Arbor
被験者募集中観察研究健康なボランティア歓迎
14歳〜18歳 · 全性別 · 2026/07/13更新 · NCT06007404Michigan Men's Diabetes Project III(MenDIII): Mind and Motion
- University of Michigan, Ann Arbor
被験者募集中
18歳以上 · 男性 · 2026/06/12更新 · NCT06574035Mechanism of SGLT2 Inhibition in the Kidney
- University of Michigan, Ann Arbor
被験者募集中第4相参加者への支払いあり
18歳〜80歳 · 全性別 · 2026/06/11更新 · NCT06291155HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
- Arcturus Healthcare, PLC, Troy Internal Medicine Research Division, Troy
被験者募集中第2相
18歳以上 · 全性別 · 2026/04/23更新 · NCT07546929RESET System Pivotal Trial (Rev F)
- Michigan Medicine, Division of Gastroenterology and Hepatology, Ann Arbor
被験者募集中
22歳〜65歳 · 全性別 · 2024/07/18更新 · NCT04101669ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。